Home › Funds › GREAT POINT PARTNERS LLC › ABVX

GREAT POINT PARTNERS LLC position in ABVX

ABIVAX SA · Health Care

GREAT POINT PARTNERS LLC reported holding 155,000 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$15.3M, representing 3.84% of its reported portfolio and ranking #12 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed ABVX holdings in 10 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)155.00K sh
Reported value held$15.35M
Portfolio Weight3.84%
First reportedQ4 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's ABVX position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in ABVX in Q4 2023 at 1,550,000 shares (US$16.6M). The position peaked in Q1 2024 at 2,488,483 shares, worth US$35.6M. Across 10 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 155,000 shares valued at US$15.3M — a reduction of -49,314 shares quarter over quarter.. Notable position changes include a 61% increase in Q1 2024 (shares fell 8% over the following quarter), a 88% trim in Q3 2025 (shares rose 59% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.55M $16.59M New
Q1 2024 2.49M $35.59M Add
Q2 2024 2.47M $32.68M Reduce
Q3 2024 2.13M $24.52M Reduce
Q4 2024 1.65M $12.07M Reduce
Q1 2025 1.64M $10.24M Reduce
Q2 2025 1.29M $9.88M Reduce
Q3 2025 150.00K $12.73M Reduce
Q2 2026 204.31K $27.23M New
Q3 2026 155.00K $15.35M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 58 other funds we track also report a position in ABVX — the largest reported positions include Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$398.2M), Vestal Point Capital, LP (US$392.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held ABVX?

GREAT POINT PARTNERS LLC has disclosed ABVX holdings in 10 of the last 12 reported quarters, going back to Q4 2023.

What is GREAT POINT PARTNERS LLC's current position in ABVX?

As of Q3 2026, GREAT POINT PARTNERS LLC holds 155.00K shares of ABVX (ABIVAX SA), valued at $15.35M, representing 3.84% of its reported portfolio and ranking #12.

Has GREAT POINT PARTNERS LLC been buying or selling ABVX?

In the latest 13F filing (Q3 2026), GREAT POINT PARTNERS LLC reduced its position in ABVX. The position peaked in Q1 2024 at 2.49M shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include Helikon Investments Ltd, Darwin Global Management, Ltd., Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.